DON-ANDRE JACKSON
Allopathic & Osteopathic Physicians|Internal Medicine|Rheumatology DERBY, CT NPI 1508250952
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Rheumatology CT Janssen Biotech, Inc. All categories
General Payments — all program years on this page
$8,570.97
- Category: General Payments
- Program years: PY2021–2024
- Record count: 290
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $3,556.94 across 77 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,853.44 | 75 |
| Consulting Fee | $1,680.00 | 1 |
| Travel and Lodging | $23.50 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Janssen Biotech, Inc. | $2,170.47 | 13 |
| ABBVIE INC. | $402.75 | 23 |
| Kiniksa Pharmaceuticals International, plc | $143.42 | 5 |
| UCB, Inc. | $134.37 | 8 |
| Aurinia Pharma U.S., Inc. | $78.31 | 3 |
| Lilly USA, LLC | $72.85 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $64.80 | 3 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $60.83 | 3 |
| Acerta Pharma LLC | $52.23 | 2 |
| Janssen Scientific Affairs, LLC | $50.79 | 1 |
| GENZYME CORPORATION | $48.91 | 2 |
| Sandoz Inc. | $48.69 | 2 |
| Fresenius Kabi USA, LLC | $48.32 | 2 |
| Amgen Inc. | $42.86 | 2 |
| Actelion Pharmaceuticals US, Inc. | $32.03 | 1 |
| GlaxoSmithKline, LLC. | $29.24 | 1 |
| E.R. Squibb & Sons, L.L.C. | $28.03 | 1 |
| PFIZER INC. | $24.11 | 1 |
| Organon LLC | $23.93 | 1 |
By program year
Records — PY2024 (77)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.